Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Nov-Dec;40(6 Suppl):S187-91.
doi: 10.1016/j.jelectrocard.2007.05.036.

Gene therapy approaches to ventricular tachyarrhythmias

Affiliations

Gene therapy approaches to ventricular tachyarrhythmias

J Kevin Donahue et al. J Electrocardiol. 2007 Nov-Dec.

Abstract

Ventricular tachycardia arising from a healed myocardial infarction scar continues to be a significant cause of morbidity and mortality. Drug therapy has been inadequate to meet this challenge, and implantable devices are limited by expense and technical problems. We have proposed the use of gene therapy for cardiac arrhythmias. In this review, we present a model of postinfarct ventricular tachycardia, a method for gene delivery to this area, and results of KCNH2-G628S gene transfer to manipulate cellular refractory properties in the arrhythmia model.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Ventricular tachycardia in the porcine myocardial infarction model. A. ECG example showing identical VT morphology and cycle length from one week to the next in a representative animal. B. Intracardiac electrograms during sinus rhythm (SR) show low amplitude, fractionated signals in the anterior septal region (splines D and E). The ventricular tachycardia recording demonstrates slow, progressive activation of this region through diastole. C. Hematoxylin-Eosin stained microsection of the infarct border zone reveals surviving strands of myocardium surrounded by fibrotic scar in the anterior septum. (with permission from Sasano et al. Nat Med)
Figure 2
Figure 2
KCNH2-G628S gene transfer in the MI-VT model. A. Prior to gene transfer, VT was repeatedly inducible in all animals. After gene transfer, no arrhythmias could be induced in any KCNH2-G628S infected animal, but all control animals remained inducible. B. Example of triple extra stimuli in a representative G628S animal. The top tracing shows VT induced with triple extra stimuli immediately before gene transfer. The bottom two panels show triple extra stimuli one week after gene transfer. The middle panel shows the tightest possible coupling of S2-4 where all 3 extra stimuli capture the ventricles (which is tighter than the intervals that consistently produced VT before gene transfer). The bottom panel shows refractory stimulation. After progressive tightening of S2-4 coupling intervals, extra stimuli are now so tightly coupled that the ventricles are refractory to stimulation. (with permission from Sasano et al. Nat Med)

Similar articles

Cited by

References

    1. American Heart Association . 2001 Heart and Stroke Statistical Update. American Heart Association; Dallas, TX: 2002.
    1. Maisel W, Moynahan M, Zuckerman B, Gross T, Tovar O, Tillman D, Schultz D. Pacemaker and ICD generator malfunctions. JAMA. 2006;295:1901–1906. - PubMed
    1. Gould P, Krahn A. Canadian Heart Rhythm Society Working Group on Device Advisories. Complications associated with implantable cardioverter-defibrillator replacement in response to device advisories. JAMA. 2006;295:1907–1911. - PubMed
    1. Estes N. Primary prevention of sudden cardiac death: a rational approach to the use of the implantable cardioverter defibrillator. J Int Card EP. 2005;13:91–93. - PubMed
    1. Sasano T, McDonald A, Kikuchi K, Donahue JK. Molecular ablation of ventricular tachycardia after myocardial infarction. Nat Med. 2006;12:1256–1258. - PMC - PubMed

Publication types

Substances